A team from the Technical University of Munich (TUM) in Germany has shown for the first time how artificially grown mini-intestines can be used in nutritional and diabetic research.
Among their many functions, intestinal hormones, known as incretins, control blood glucose levels, appetite and fat metabolism.
Diabetics and obese individuals have already been successfully treated with drugs based on the mechanisms of action of these hormones.
However, still too little is known about the precise mechanism behind incretin release.
To do so, they first isolate small pieces of intestine containing stem cells - in this case from mice. In the next step, a nutrient solution in a test tube stimulates the stem cells to develop into an organ-like structure.
In just a few days, a spherical organoid forms that measures just a quarter of a millimetre across and is suitable for use in research.
"The special thing about our scientific work on the intestinal organoid is that we can observe its inner workings," said Dr Tamara Zietek of the Department of Nutrition Physiology.
The intestinal organoid can actively absorb nutrients and drugs, release hormones after activation by nutrients, transmit signals within the intestinal cells to control these processes.
"Until now, it was not possible to investigate these processes in a single model, because conventional models are unsuitable for all these measurements," said Zietek.
In addition, once mini-intestines have been grown, researchers can work with them for months, because they can be replicated in the laboratory.
"This drastically reduces the number of experimental animals needed," Zietek added.
The study appears in the journal Scientific Reports.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
